Skip to main content
. 2022 Dec 27;328(24):2412–2421. doi: 10.1001/jama.2022.22847

Figure 1. Study Flow and Penetrance of PKD1 and PKD2 Variants.

Figure 1.

Evaluation of 174 172 patients with exome sequencing revealed loss-of-function variants in PKD1 and PKD2 or in-frame deletions and missense variants in PKD1 and PKD2 classified as likely pathogenic in the Mayo PKD database. ADPKD indicates autosomal dominant polycystic kidney disease; ICD-9, International Classification of Diseases, Ninth Revision; ICD-10, International Statistical Classification of Diseases and Related Health Problems, Tenth Revision.

aThere is overlap of 131 individuals in both the genotype-first and the phenotype-first analyses.

bADPKD diagnosis defined as having 1 or more of the following ICD-9 or ICD-10 codes in electronic health record: Q61.2, Q61.3, 753.12, or 753.13.

cSee Figure 2 and Figure 3 for details.

dClassified as likely pathogenic in the Mayo PKD database.

eChart review by radiologist and nephrologist.